SECSONAR

$TRDA

Entrada Therapeutics, Inc.

NASDAQ

Up 12% since last report

65% below 52-week high

Insider cost basis

Insiders bought — stock holding above

+30.3%vs buy

Insider buy $5.86Now $7.64

Find before everyone else

SEC filings, insider trades & earnings for TRDA — in one place.